
UTI Healthcare Fund (G)
Equity · Sectoral
20.06%
Last 1 year
- Exit Load
- 1.00%
- Expense Ratio
- 2.22%
- Min. AmountMin. SIP Amount
- ₹25
- Min. Lump SumMin. Lump sum
- ₹5,000
Historical View
Return Calculator
- Invested Amount
- ₹9,00,000
- Calculated AmountCurrent Value
- ₹12,78,948
- IRR
- 21.854%
- Absolute Gain
- +₹3,78,948 (+42.1%)
Returns & Rankings
Category: Equity Sectoral


63 ProductsEquity Sectoral Funds


63 ProductsWealthy Score
Return Score rates how well the fund has rewarded investors over time, comparing its returns across periods with other funds in its category.
- 1Y Returns
- 20.1%
- 3Y Returns
- 21.9%
- 5Y Returns
- 16.2%
- Alpha
- 15.64
Holding Analysis
Equity/Debt/Cash Split
- Equity98%
- Debt2%
- Others0%
Market Cap Weightage
- Mid Cap40.5%
- Small Cap34%
- Large Cap23.5%
- Others2%
Sector allocation
- Healthcare97%
- Debt2%
- Materials1%
- Others0%
Top 10 HoldingsTop Holdings
| Stocks | Sector | Percentage |
|---|---|---|
| Sun Pharma.Inds. | Pharmaceuticals | 7.44% |
| Divi's Lab. | Pharmaceuticals | 6.46% |
| Dr Reddy's Labs | Pharmaceuticals | 5.78% |
| Ajanta Pharma | Pharmaceuticals | 4.29% |
| Max Healthcare | Healthcare | 4.2% |
| Gland Pharma | Pharmaceuticals | 3.89% |
| Apollo Hospitals | Healthcare | 3.83% |
| Alkem Lab | Pharmaceuticals | 3.66% |
| Lupin | Pharmaceuticals | 3.65% |
| Global Health | Healthcare | 3.37% |
- 7.44%
Sun Pharma.Inds.
Pharmaceuticals
- 6.46%
Divi's Lab.
Pharmaceuticals
- 5.78%
Dr Reddy's Labs
Pharmaceuticals
- 4.29%
Ajanta Pharma
Pharmaceuticals
- 4.2%
Max Healthcare
Healthcare
Top Funds in the Category
| Fund Name | Rating | Category | 1Y | 3Y |
|---|---|---|---|---|
| — | Equity | 16.23% | 29.6% | |
| — | Equity | 28.41% | 28.89% | |
| — | Equity | 23.71% | 23.26% | |
| — | Equity | 20.06% | 21.85% | |
| — | Equity | 24.28% | 21.75% |
Peer Comparison
UTI Healthcare Fund (G)
- 1 Y Return
- 20.06%
- 3 Y Return
- 21.85%
- 5 Y Return
- 16.18%
Nifty 50
- 1 Y Return
- -2.32%
- 3 Y Return
- 9.41%
- 5 Y Return
- 8.00%
Investment Objective
The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Fund Management

Kamal Gada
Mr. Kamal Gada is Senior Associate Vice President. He is a CFA Charter holder from CFA Institute. He has completed CA from ICAI. He graduated in Bachelor of Commerce in 2003 from Mumbai University. He began his career with BPCL as Senior Accounts Officer in 2004. Kamal joined UTI AMC in 2008 as Research Analyst. Presently he has been designated as Fund Manager for Overseas Investments. He has over 12 years of experience in Equity Research.
Riskometer
- Risk Score
- 6
- Risk Level
- Very High
Advanced Ratios
- AlphaReturn earned over the benchmark after adjusting for risk. Higher is better.
- 15.64
- BetaHow much the fund moves with the market. Above 1 means more volatile than the market.
- 0.70
- SRSharpe Ratio: return earned per unit of total risk taken. Higher is better.
- 0.99
- SDStandard Deviation: how much returns swing around their average. Lower means steadier returns.
- 15.99
- TRTreynor Ratio: return earned per unit of market risk (beta). Higher is better.
- 0.06
- P/EPrice to Earnings of the stocks the fund holds. Higher means a pricier portfolio.
- 49.76
Tax Implication
STCG Tax: 20% if redeemed before 1 Year. LTCG Tax: 12.5% exceeding Rs. 1,25,000/- post 1 Year
FAQs
UTI Healthcare Fund – Regular Plan - Growth was launched 27 years ago and has delivered annualised returns (CAGR) of 13.83% since inception. Here is how it compares with the category average:
Period Fund Category average 1 Year 20.06% 6.93% 3 Years 21.85% 14.57% 5 Years 16.18% 11.55% Since Inception 13.83% Returns as on 18 Nov 2026. 1-year returns are absolute; returns above 1 year are CAGR. Past performance may or may not be sustained in future.
The expense ratio of UTI Healthcare Fund – Regular Plan - Growth is 2.22%. This is the annual fee for managing and operating the fund. It is adjusted in the daily NAV, so the returns you see are already net of this cost.
UTI Healthcare Fund is rated Very High risk on the SEBI riskometer. The riskometer has six levels, from Low to Very High, and fund houses review it every month.
You can start an SIP in UTI Healthcare Fund with ₹25 a month, or invest a lump sum of ₹5,000. Additional investments start at ₹1,000.
UTI Healthcare Fund charges an exit load of 1% if redeemed within 1 year of investment. The exit load is deducted from the redemption amount.
No, UTI Healthcare Fund has no lock-in period, so you can redeem anytime. An exit load may apply on early redemption.
UTI Healthcare Fund manages assets (AUM) of approximately ₹1,433 Cr.
As on 31 Oct 2026, UTI Healthcare Fund holds 48 securities. These are its top 10 holdings:
Company % of portfolio Sun Pharma.Inds. 7.44% Divi's Lab. 6.46% Dr Reddy's Labs 5.78% Ajanta Pharma 4.29% Max Healthcare 4.20% Gland Pharma 3.89% Apollo Hospitals 3.83% Alkem Lab 3.66% Lupin 3.65% Global Health 3.37% As on 31 Oct 2026, these are the fund's largest sector allocations:
Sector % of portfolio Healthcare 97.02% Debt 1.96% Materials 0.97% Others 0.03% If you invested through a Wealthy partner, you can place a redemption request in the Wealthy app, or ask your partner to do it for you. If you invested elsewhere, you can redeem through the UTI Mutual Fund website, MF Central or KARVY. The money is credited to your registered bank account, usually within a few working days. Exit load and capital gains tax may apply.












